UPDATED May 16, 2024
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
TXG | US$25.59 | -3.0% | -53.5% | US$3.2b | US$41.14 | PS4.9x | E63.2% | n/a | ||
TECH | US$82.84 | -0.8% | -0.5% | US$13.2b | US$83.64 | PE64.3x | E14.9% | 0.4% | ||
TWST | US$46.50 | -3.8% | 254.7% | US$2.8b | US$43.38 | PS9.8x | E20.5% | n/a | ||
CRSP | US$55.67 | -2.3% | -12.3% | US$4.8b | US$86.78 | PS17.4x | E42.7% | n/a | ||
RXRX | US$9.51 | -5.0% | 47.9% | US$2.3b | US$13.00 | PS48.9x | E-9.4% | n/a | ||
SANA | US$8.55 | -7.8% | 20.1% | US$1.9b | US$11.50 | PB5x | E0.8% | n/a | ||
BIO | US$295.73 | -1.7% | -22.2% | US$8.5b | US$393.80 | PS3.2x | E32.8% | n/a | ||
AVTR | US$24.98 | -0.9% | 19.8% | US$17.1b | US$27.77 | PE65.3x | E35.0% | n/a | ||
CGEM | US$23.81 | -10.9% | 170.6% | US$1.5b | US$33.00 | PB3.2x | E-7.7% | n/a | ||
RPRX | US$27.88 | -1.2% | -17.1% | US$16.9b | US$45.75 | PE15.7x | E12.5% | 3.0% | ||
IONS | US$37.62 | -4.1% | 2.7% | US$5.7b | US$57.95 | PS7.1x | E36.1% | n/a | ||
IBRX | US$7.75 | -4.3% | 175.8% | US$5.6b | US$7.50 | PS17747.2x | E61.7% | n/a | ||
BRKR | US$75.82 | -2.2% | 1.7% | US$11.3b | US$85.70 | PE27.4x | E6.8% | 0.3% | ||
EXAS | US$51.95 | -2.6% | -36.1% | US$9.8b | US$86.59 | PS3.8x | E65.9% | n/a | ||
RGEN | US$171.03 | -2.8% | 9.2% | US$9.8b | US$204.16 | PE643.9x | E60.5% | n/a | ||
MEDP | US$393.28 | -3.1% | 88.0% | US$12.5b | US$423.17 | PE38.9x | E13.8% | n/a | ||
CRL | US$224.75 | -3.4% | 12.8% | US$12.0b | US$265.60 | PE26x | E13.6% | n/a | ||
ICLR | US$315.83 | -1.9% | 51.7% | US$26.6b | US$354.14 | PE38.2x | E14.1% | n/a | ||
TEVA | US$16.30 | -2.9% | 97.3% | US$19.0b | US$17.34 | PS1.2x | E40.4% | 0% | ||
BMRN | US$76.97 | -4.3% | -16.2% | US$14.6b | US$109.32 | PE71.1x | E29.8% | n/a | ||
TMO | US$597.15 | -0.3% | 14.1% | US$228.7b | US$627.27 | PE37.8x | E10.6% | 0.3% | ||
BIIB | US$230.04 | -2.2% | -24.7% | US$34.3b | US$285.92 | PE28.7x | E17.8% | n/a | ||
VKTX | US$69.06 | -11.5% | 200.7% | US$7.6b | US$112.45 | PB8.2x | E4.8% | n/a | ||
BMY | US$44.11 | -1.0% | -32.9% | US$90.3b | US$53.19 | PS2x | E43.8% | 5.4% |